Search for: "TEVA USA, INC."
Results 481 - 500
of 646
Sort by Relevance
|
Sort by Date
30 Apr 2011, 5:22 am
USA, Inc., 518 F.3d 1353, 1365 (Fed. [read post]
29 Apr 2011, 1:03 pm
USA, Inc., 518 F.3d 1353, 1365 (Fed. [read post]
29 Apr 2011, 7:43 am
Teva Parenteral Medicines Inc. [read post]
24 Apr 2011, 3:45 pm
., Inc. v. [read post]
21 Apr 2011, 1:36 pm
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
13 Apr 2011, 5:13 pm
By way of that unlawful conduct, Defendants are also quelling competition in the United States market for Aricept® tablets, at least by manipulating the Hatch-Waxman Act in a manner that effectively and substantially delays the generic drug manufacturer, Teva Pharmaceuticals USA, Inc., from bringing its generic version of Aricept® tablets, which has been tentatively approved by the FDA, to market in the United States. [read post]
6 Apr 2011, 12:18 am
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog) Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and sets… [read post]
5 Apr 2011, 2:35 pm
Par opposed the Motion to Dismiss arguing that pursuant to the Federal Circuit’s decision in Teva Pharmaceuticals USA, Inc. v. [read post]
24 Mar 2011, 12:53 pm
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical Association Title: Stovall v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
10 Mar 2011, 3:18 pm
Teva Pharmaceuticals USA, Inc., Civ. [read post]
23 Feb 2011, 10:58 am
USA, Inc., 557 F.3d 1346 (Fed. [read post]
17 Feb 2011, 6:59 pm
USA, Inc. v. [read post]
28 Jan 2011, 11:38 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
18 Jan 2011, 7:42 am
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
17 Jan 2011, 9:27 am
USA, Inc. v. [read post]
12 Jan 2011, 6:55 am
Teva Pharmaceuticals USA Inc., et. al., 1-08-cv-00464 (DED January 7, 2011, Order) (Bartle, C.J.) [read post]
28 Dec 2010, 10:58 am
USA, Inc. v. [read post]
13 Dec 2010, 4:55 pm
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
22 Nov 2010, 1:24 pm
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
